One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C

BACKGROUND: Entecavir (ETV) is a potent and selective nucleotide analog with significant activity against hepatitis B virus (HBV). ETV maleate is a derivative compound of ETV and was reported to have an efficacy and safety profile that is comparable to ETV (Baraclude) when used in Chinese patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jing-Hang, Wang, Sa, Zhang, Da-Zhi, Yu, Yan-Yan, Si, Chong-Wen, Zeng, Zheng, Xu, Zhong-Nan, Li, Jun, Mao, Qing, Tang, Hong, Sheng, Ji-Fang, Chen, Xin-Yue, Ning, Qin, Shi, Guang-Feng, Xie, Qing, Zhang, Xi-Quan, Dai, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561570/
https://www.ncbi.nlm.nih.gov/pubmed/36246814
http://dx.doi.org/10.12998/wjcc.v10.i28.10085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561570/
https://www.ncbi.nlm.nih.gov/pubmed/36246814
http://dx.doi.org/10.12998/wjcc.v10.i28.10085

Ejemplares similares